The table below shows Disc Medicine, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$180.39M
-$93.93M
-$73.46M
-$42.25M
-$27.53M
-$32.71M
Capital expenditure
$933.00K
$505.00K
$89.00K
$151.00K
$68.00K
$22.00K
Investing cash flow
-$394.30M
-$292.33M
-$89.00K
-$151.00K
-$68.00K
-$22.00K
Dividends paid
-
-
-
-
IRON operating cash flow (10-K history)
Disc Medicine, Inc. reported operating cash flow of -$180.39M for fiscal year 2025. That is down 92.1% from -$93.93M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$32.71M (FY 2020) to -$180.39M. Figures come from the company's audited annual reports as filed with the SEC.